Genomic epidemiology cohorts in korea: Present and the future

Keun Young Yoo, Hai Rim Shin, Soung Hoon Chang, Bo Youl Choi, Yun Chul Hong, Dong Hyun Kim, Daehee Kang, Nam Han Cho, Chol Shin, Young Woo Jin

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Human genome epidemiology involves the application of genetic technology to assess the impact of variations at the DNA level on health and disease. Recent developments in molecular biology allow epidemiologists to use biomarkers to determine an individual's predisposition to disease and to detect disease at an early stage. Moreover, advances in genomics and proteomicscould play a central role in research into disease prediction and prevention. Large scale population-based cohort prospective studies offer the most comprehensive approach to the delineation of gene function, the effects of the environment, and their interactions. The Korean Multi-center Cancer Cohort (KMCC), under construction since 1993, is the first multi-center prospective cohort to identify risk factors for cancer in Korea. Data on general lifestyle, physical activity, diet, reproductive factors, and agricultural exposure are obtained through direct interview using a structured questionnaire.Anthropometric measurements and clinical laboratory findings are also collected using a web-based data entry system. Moreover, biological materials have been banked [blood (serum, plasma, buffy coat, packed erythrocytes)is stored at -70°C and urine at -20°C] for future analysis. Several other cohorts including the Korean National Cancer Center (KNCC) Cohort, the Korean Health Examinees (KOEX) Cohort, the Korean Health and Genome Epidemiologic Study (KHGES), and the Yang Pyeong Cohort have also been launched since the KMCC cohort was initiated. Even though these cohorts have collected similar data and biospecimen, questionnaires and protocols used have not been standardized. However, these cohortstudies are of increased scope and have been designed to detect risk factors for cardiovascular disease, metabolic syndrome, and cancer. Subjects have been followed up actively by health personnel in different regions and by using record linkages with the central cancer registry, and the national death certificate and national health insurance claim databases. As of August 2004, the total number of subjects enrolled in all cohorts with archived biologic specimens was around 80,000. A new genomic cohort has been launched since 2001 in Korea, for which the target number of subjects is 250,000 men and women over the next 5 years. This article describes the goals and the designs of each of the abovementioned cohorts.

Original languageEnglish
Pages (from-to)238-243
Number of pages6
JournalAsian Pacific Journal of Cancer Prevention
Volume6
Issue number3
Publication statusPublished - 2005 Dec 1

Fingerprint

Korea
Epidemiology
Neoplasms
Death Certificates
Health
National Health Programs
Human Genome
Genomics
Information Systems
Health Personnel
Health Status
Registries
Life Style
Epidemiologic Studies
Molecular Biology
Cohort Studies
Cardiovascular Diseases
Erythrocytes
Biomarkers
Urine

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Public Health, Environmental and Occupational Health
  • Epidemiology

Cite this

Yoo, K. Y., Shin, H. R., Chang, S. H., Choi, B. Y., Hong, Y. C., Kim, D. H., ... Jin, Y. W. (2005). Genomic epidemiology cohorts in korea: Present and the future. Asian Pacific Journal of Cancer Prevention, 6(3), 238-243.

Genomic epidemiology cohorts in korea : Present and the future. / Yoo, Keun Young; Shin, Hai Rim; Chang, Soung Hoon; Choi, Bo Youl; Hong, Yun Chul; Kim, Dong Hyun; Kang, Daehee; Cho, Nam Han; Shin, Chol; Jin, Young Woo.

In: Asian Pacific Journal of Cancer Prevention, Vol. 6, No. 3, 01.12.2005, p. 238-243.

Research output: Contribution to journalArticle

Yoo, KY, Shin, HR, Chang, SH, Choi, BY, Hong, YC, Kim, DH, Kang, D, Cho, NH, Shin, C & Jin, YW 2005, 'Genomic epidemiology cohorts in korea: Present and the future', Asian Pacific Journal of Cancer Prevention, vol. 6, no. 3, pp. 238-243.
Yoo KY, Shin HR, Chang SH, Choi BY, Hong YC, Kim DH et al. Genomic epidemiology cohorts in korea: Present and the future. Asian Pacific Journal of Cancer Prevention. 2005 Dec 1;6(3):238-243.
Yoo, Keun Young ; Shin, Hai Rim ; Chang, Soung Hoon ; Choi, Bo Youl ; Hong, Yun Chul ; Kim, Dong Hyun ; Kang, Daehee ; Cho, Nam Han ; Shin, Chol ; Jin, Young Woo. / Genomic epidemiology cohorts in korea : Present and the future. In: Asian Pacific Journal of Cancer Prevention. 2005 ; Vol. 6, No. 3. pp. 238-243.
@article{d76bcddbf4b34e9baeefb5dd6fafda93,
title = "Genomic epidemiology cohorts in korea: Present and the future",
abstract = "Human genome epidemiology involves the application of genetic technology to assess the impact of variations at the DNA level on health and disease. Recent developments in molecular biology allow epidemiologists to use biomarkers to determine an individual's predisposition to disease and to detect disease at an early stage. Moreover, advances in genomics and proteomicscould play a central role in research into disease prediction and prevention. Large scale population-based cohort prospective studies offer the most comprehensive approach to the delineation of gene function, the effects of the environment, and their interactions. The Korean Multi-center Cancer Cohort (KMCC), under construction since 1993, is the first multi-center prospective cohort to identify risk factors for cancer in Korea. Data on general lifestyle, physical activity, diet, reproductive factors, and agricultural exposure are obtained through direct interview using a structured questionnaire.Anthropometric measurements and clinical laboratory findings are also collected using a web-based data entry system. Moreover, biological materials have been banked [blood (serum, plasma, buffy coat, packed erythrocytes)is stored at -70°C and urine at -20°C] for future analysis. Several other cohorts including the Korean National Cancer Center (KNCC) Cohort, the Korean Health Examinees (KOEX) Cohort, the Korean Health and Genome Epidemiologic Study (KHGES), and the Yang Pyeong Cohort have also been launched since the KMCC cohort was initiated. Even though these cohorts have collected similar data and biospecimen, questionnaires and protocols used have not been standardized. However, these cohortstudies are of increased scope and have been designed to detect risk factors for cardiovascular disease, metabolic syndrome, and cancer. Subjects have been followed up actively by health personnel in different regions and by using record linkages with the central cancer registry, and the national death certificate and national health insurance claim databases. As of August 2004, the total number of subjects enrolled in all cohorts with archived biologic specimens was around 80,000. A new genomic cohort has been launched since 2001 in Korea, for which the target number of subjects is 250,000 men and women over the next 5 years. This article describes the goals and the designs of each of the abovementioned cohorts.",
author = "Yoo, {Keun Young} and Shin, {Hai Rim} and Chang, {Soung Hoon} and Choi, {Bo Youl} and Hong, {Yun Chul} and Kim, {Dong Hyun} and Daehee Kang and Cho, {Nam Han} and Chol Shin and Jin, {Young Woo}",
year = "2005",
month = "12",
day = "1",
language = "English",
volume = "6",
pages = "238--243",
journal = "Asian Pacific Journal of Cancer Prevention",
issn = "1513-7368",
publisher = "Asian Pacific Organization for Cancer Prevention",
number = "3",

}

TY - JOUR

T1 - Genomic epidemiology cohorts in korea

T2 - Present and the future

AU - Yoo, Keun Young

AU - Shin, Hai Rim

AU - Chang, Soung Hoon

AU - Choi, Bo Youl

AU - Hong, Yun Chul

AU - Kim, Dong Hyun

AU - Kang, Daehee

AU - Cho, Nam Han

AU - Shin, Chol

AU - Jin, Young Woo

PY - 2005/12/1

Y1 - 2005/12/1

N2 - Human genome epidemiology involves the application of genetic technology to assess the impact of variations at the DNA level on health and disease. Recent developments in molecular biology allow epidemiologists to use biomarkers to determine an individual's predisposition to disease and to detect disease at an early stage. Moreover, advances in genomics and proteomicscould play a central role in research into disease prediction and prevention. Large scale population-based cohort prospective studies offer the most comprehensive approach to the delineation of gene function, the effects of the environment, and their interactions. The Korean Multi-center Cancer Cohort (KMCC), under construction since 1993, is the first multi-center prospective cohort to identify risk factors for cancer in Korea. Data on general lifestyle, physical activity, diet, reproductive factors, and agricultural exposure are obtained through direct interview using a structured questionnaire.Anthropometric measurements and clinical laboratory findings are also collected using a web-based data entry system. Moreover, biological materials have been banked [blood (serum, plasma, buffy coat, packed erythrocytes)is stored at -70°C and urine at -20°C] for future analysis. Several other cohorts including the Korean National Cancer Center (KNCC) Cohort, the Korean Health Examinees (KOEX) Cohort, the Korean Health and Genome Epidemiologic Study (KHGES), and the Yang Pyeong Cohort have also been launched since the KMCC cohort was initiated. Even though these cohorts have collected similar data and biospecimen, questionnaires and protocols used have not been standardized. However, these cohortstudies are of increased scope and have been designed to detect risk factors for cardiovascular disease, metabolic syndrome, and cancer. Subjects have been followed up actively by health personnel in different regions and by using record linkages with the central cancer registry, and the national death certificate and national health insurance claim databases. As of August 2004, the total number of subjects enrolled in all cohorts with archived biologic specimens was around 80,000. A new genomic cohort has been launched since 2001 in Korea, for which the target number of subjects is 250,000 men and women over the next 5 years. This article describes the goals and the designs of each of the abovementioned cohorts.

AB - Human genome epidemiology involves the application of genetic technology to assess the impact of variations at the DNA level on health and disease. Recent developments in molecular biology allow epidemiologists to use biomarkers to determine an individual's predisposition to disease and to detect disease at an early stage. Moreover, advances in genomics and proteomicscould play a central role in research into disease prediction and prevention. Large scale population-based cohort prospective studies offer the most comprehensive approach to the delineation of gene function, the effects of the environment, and their interactions. The Korean Multi-center Cancer Cohort (KMCC), under construction since 1993, is the first multi-center prospective cohort to identify risk factors for cancer in Korea. Data on general lifestyle, physical activity, diet, reproductive factors, and agricultural exposure are obtained through direct interview using a structured questionnaire.Anthropometric measurements and clinical laboratory findings are also collected using a web-based data entry system. Moreover, biological materials have been banked [blood (serum, plasma, buffy coat, packed erythrocytes)is stored at -70°C and urine at -20°C] for future analysis. Several other cohorts including the Korean National Cancer Center (KNCC) Cohort, the Korean Health Examinees (KOEX) Cohort, the Korean Health and Genome Epidemiologic Study (KHGES), and the Yang Pyeong Cohort have also been launched since the KMCC cohort was initiated. Even though these cohorts have collected similar data and biospecimen, questionnaires and protocols used have not been standardized. However, these cohortstudies are of increased scope and have been designed to detect risk factors for cardiovascular disease, metabolic syndrome, and cancer. Subjects have been followed up actively by health personnel in different regions and by using record linkages with the central cancer registry, and the national death certificate and national health insurance claim databases. As of August 2004, the total number of subjects enrolled in all cohorts with archived biologic specimens was around 80,000. A new genomic cohort has been launched since 2001 in Korea, for which the target number of subjects is 250,000 men and women over the next 5 years. This article describes the goals and the designs of each of the abovementioned cohorts.

UR - http://www.scopus.com/inward/record.url?scp=32944476959&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=32944476959&partnerID=8YFLogxK

M3 - Article

C2 - 16235980

AN - SCOPUS:32944476959

VL - 6

SP - 238

EP - 243

JO - Asian Pacific Journal of Cancer Prevention

JF - Asian Pacific Journal of Cancer Prevention

SN - 1513-7368

IS - 3

ER -